NDC 51759-204

AJOVY

Fremanezumab-vfrm

AJOVY is a Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Teva Pharmaceuticals Usa, Inc.. The primary component is Fremanezumab.

• Product ID: 51759-204_08ae1956-25f5-4553-be30-333c558fd801
• NDC: 51759-204
• Product Type: Human Prescription Drug
• Proprietary Name: AJOVY
• Generic Name: Fremanezumab-vfrm
• Dosage Form: Injection
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2018-09-15
• Marketing Category: BLA / BLA
• Application Number: BLA761089
• Labeler Name: Teva Pharmaceuticals USA, Inc.
• Substance Name: FREMANEZUMAB
• Active Ingredient Strength: 225 mg/1.5mL
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 51759-204-10

1 SYRINGE, GLASS in 1 CARTON (51759-204-10) > 1.5 mL in 1 SYRINGE, GLASS

• Marketing Start Date: 2018-09-15
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 51759-204-11 [51759020411]

AJOVY INJECTION

• Marketing Category: BLA
• Application Number: BLA761089
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2018-09-15

NDC 51759-204-10 [51759020410]

AJOVY INJECTION

• Marketing Category: BLA
• Application Number: BLA761089
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2018-09-15

Drug Details

Active Ingredients

Ingredient	Strength
FREMANEZUMAB	225 mg/1.5mL

OpenFDA Data

• SPL SET ID: 98e344ea-5916-4947-b6f2-4a76ccc04b6b
• Manufacturer:
  • Teva Pharmaceuticals USA, Inc.
• UNII:
  • PF8K38CG54
• RxNorm Concept Unique ID - RxCUI:
  • 2056700
  • 2056695

Medicade Reported Pricing

51759020410 AJOVY 225 MG/1.5 ML SYRINGE

Pricing Unit: ML | Drug Type:

NDC Crossover Matching brand name "AJOVY" or generic name "Fremanezumab-vfrm"

NDC	Brand Name	Generic Name
51759-202	AJOVY	fremanezumab-vfrm
51759-204	AJOVY	fremanezumab-vfrm